Pharmacokinetics and Safety of Indinavir in Human Immunodeficiency Virus-Infected Pregnant Women
Open Access
- 1 February 2007
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (2) , 783-786
Abstract
Human immunodeficiency virus-infected women (n= 16) received indinavir (800 mg three times a day) plus zidovudine plus lamivudine from 14 to 28 weeks of gestation to 12 weeks postpartum. Two women and eight infants experienced grade 3 or 4 toxicities that were possibly treatment related. Indinavir area under the plasma concentration-time curve was 68% lower antepartum versus postpartum, suggesting increased intestinal and/or hepatic CYP3A activity during pregnancy.Keywords
This publication has 12 references indexed in Scilit:
- Changes in Pharmacokinetics of Anti-HIV Protease Inhibitors during Pregnancy: The Role of CYP3A and P-glycoproteinThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancyAmerican Journal of Obstetrics and Gynecology, 2005
- Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.Current HIV Research, 2004
- Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)Current Medical Research and Opinion, 2004
- Therapeutic drug monitoring in HIV infection: current status and future directionsAIDS, 2002
- Transendothelial migration of leukocytes carrying infectious HIV-1: an indicator of adverse prognosisAIDS, 2002
- Physiologic changes in pregnancy and their effect on drug dispositionSeminars in Perinatology, 2001
- HIV's pharmacokinetics, pharmacodynamics, pharmacogenetics, and pharmacogenomics.2001
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Pharmacokinetics of clorazepate in pregnant and non-pregnant womenEuropean Journal of Clinical Pharmacology, 1979